In-Licensing Lessons: Benchmarking Best Practice

For Big Pharma companies, biotechs present a world of potential opportunities to boost pipelines with reduced risk. However, it’s a very large ecosystem, which makes it difficult to identify, screen and select the assets that fit your strategy. Biotechs have big dreams and finding mutually acceptable common ground is key to a successful partnership.